Company intelligence / Profile preview

Beijing Aosaikang Pharmaceutical

Nanjing, Jiangsu, China

Ownership: Private
Employees: ~988
Development stage: Other

Overview

ASK Pharm is a major Chinese specialty and generic pharmaceutical company, publicly listed, with a pipeline blending high-revenue generic drugs and increasingly innovative biologics and small molecules. By 2025, their first Class 1 innovative drug received approval, and their CLDN18.2 monoclonal antibody (ASK B589) for gastric cancer is in Phase 3, with strong efficacy data released at ASCO GI. Their innovative oncology pipeline is expanding, and they have a strategic focus on sustainable R&D investment via generic drug profits[2][4].

Therapeutic areas: GastroenterologyInfectious DiseasesHematologyOtherOncology
Modalities: Small moleculeMonoclonal antibodyBispecific monoclonal antibodyFc fusion proteinBiosimilarChemical drugs
Industry: Biotech

Partnerships

Innovent Biologics (collaboration on Limertinib)Beimei Pharma (pediatric and digestive medicines, including Esomeprazole)Various academic collaborations (incl. Peking University Health Science Center)

Beyond the preview

Go deeper on Beijing Aosaikang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Aosaikang Pharmaceutical.

Explore the full profile